Sand Hill Global Advisors LLC Decreases Stake in CVS Health Co. (NYSE:CVS)

Sand Hill Global Advisors LLC lessened its position in shares of CVS Health Co. (NYSE:CVS) by 2.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,392 shares of the pharmacy operator’s stock after selling 1,989 shares during the quarter. Sand Hill Global Advisors LLC’s holdings in CVS Health were worth $6,190,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Atticus Wealth Management LLC raised its stake in CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 219 shares in the last quarter. USA Financial Formulas lifted its holdings in shares of CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 321 shares during the last quarter. Cornerstone Planning Group LLC grew its position in CVS Health by 111.5% in the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 243 shares in the last quarter. ZRC Wealth Management LLC increased its stake in CVS Health by 400.0% during the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after acquiring an additional 400 shares during the last quarter. Finally, Coston McIsaac & Partners lifted its stake in shares of CVS Health by 42.6% in the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after purchasing an additional 161 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Activity at CVS Health

In related news, Director Edward J. Ludwig acquired 1,000 shares of the business’s stock in a transaction dated Thursday, May 2nd. The shares were purchased at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The transaction was disclosed in a document filed with the SEC, which is available through this link. 0.24% of the stock is currently owned by corporate insiders.

CVS Health Stock Up 0.2 %

CVS stock traded up $0.14 during trading on Wednesday, hitting $57.46. 9,542,737 shares of the company’s stock traded hands, compared to its average volume of 11,949,526. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78. The firm has a market capitalization of $72.13 billion, a P/E ratio of 10.09, a PEG ratio of 0.55 and a beta of 0.56. The business has a fifty day simple moving average of $68.33 and a two-hundred day simple moving average of $72.24. CVS Health Co. has a 1 year low of $53.70 and a 1 year high of $83.25.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same quarter in the prior year, the firm posted $2.20 earnings per share. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. Sell-side analysts anticipate that CVS Health Co. will post 7.02 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.63%. CVS Health’s payout ratio is 46.75%.

Analysts Set New Price Targets

Several analysts recently weighed in on CVS shares. Wells Fargo & Company decreased their price target on CVS Health from $76.00 to $60.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 7th. SVB Leerink restated a “market perform” rating and issued a $60.00 target price (down previously from $87.00) on shares of CVS Health in a report on Wednesday, May 1st. Leerink Partnrs downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 1st. Barclays decreased their price objective on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday, May 2nd. Finally, Bank of America cut their target price on CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Nine equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $76.75.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.